(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -0.04%39.75B | -19.24%16.38B | 28.20%77.78B | 31.08%57.57B | 51.04%39.76B | 61.60%20.28B | -24.87%60.67B | --43.92B | --26.33B | --12.55B |
Operating income | -0.04%39.75B | -19.24%16.38B | 28.20%77.78B | 31.08%57.57B | 51.04%39.76B | 61.60%20.28B | -24.87%60.67B | 43.92B | 26.33B | 12.55B |
Cost of sales | -3.70%-29.11B | 12.01%-12.26B | -19.56%-56.06B | -19.76%-41B | -31.18%-28.07B | -34.86%-13.93B | 27.79%-46.89B | ---34.23B | ---21.4B | ---10.33B |
Operating expenses | -3.70%-29.11B | 12.01%-12.26B | -19.56%-56.06B | -19.76%-41B | -31.18%-28.07B | -34.86%-13.93B | 27.79%-46.89B | -34.23B | -21.4B | -10.33B |
Gross profit | -9.01%10.64B | -35.08%4.12B | 57.60%21.72B | 71.08%16.57B | 137.27%11.69B | 186.06%6.35B | -12.89%13.78B | 9.69B | 4.93B | 2.22B |
Selling expenses | -19.10%-3.51B | -25.50%-1.62B | -45.50%-6.65B | -41.14%-4.57B | -48.46%-2.94B | -50.27%-1.29B | -6.13%-4.57B | ---3.24B | ---1.98B | ---860.97M |
Administrative expenses | -9.98%-4.1B | -24.55%-2.02B | -12.11%-8.24B | -0.62%-5.59B | 1.36%-3.73B | -6.12%-1.62B | 17.68%-7.35B | ---5.55B | ---3.78B | ---1.53B |
Research and development expenses | -4.32%-971.81M | -2.31%-467.3M | 23.92%-1.94B | 31.11%-1.4B | 39.02%-931.53M | 39.02%-456.74M | 20.30%-2.55B | ---2.04B | ---1.53B | ---748.95M |
Impairment and provision | -11.05%-36.4M | ---- | 36.90%-93.42M | 50.19%-37.98M | 57.01%-32.78M | ---- | 80.17%-148.06M | ---76.24M | ---76.24M | ---- |
-Goodwill impairment | -11.05%-36.4M | ---- | 36.90%-93.42M | 50.19%-37.98M | 57.01%-32.78M | ---- | 80.17%-148.06M | ---76.24M | ---76.24M | ---- |
Operating profit | -50.06%2.03B | -99.60%11.85M | 675.94%4.8B | 507.29%4.97B | 266.63%4.06B | 424.41%2.98B | 38.52%-832.91M | -1.22B | -2.44B | -917.97M |
Financing income | 10.63%666.25M | 17.53%309.68M | 69.92%1.26B | 94.88%951.37M | 120.23%602.23M | 132.44%263.49M | 109.69%743.48M | --488.17M | --273.45M | --113.36M |
Special items of earning before tax | 13.36%895.09M | -18.70%517.42M | 377.74%1.82B | 5,426.25%1.2B | 166.38%789.62M | 70.65%636.42M | -82.17%381.71M | --21.73M | --296.42M | --372.93M |
Earning before tax | -34.17%3.59B | -78.37%838.95M | 2,597.32%7.88B | 1,102.58%7.12B | 392.10%5.45B | 998.31%3.88B | -74.38%292.29M | -710.4M | -1.87B | -431.69M |
Tax | 10.40%-1.26B | 63.94%-406.83M | -18.04%-1.99B | -79.71%-1.9B | -126.32%-1.4B | -500.26%-1.13B | -1.45%-1.69B | ---1.06B | ---619.26M | ---187.95M |
After-tax profit from continuing operations | -42.40%2.33B | -84.29%432.12M | 521.50%5.89B | 395.02%5.22B | 262.93%4.05B | 543.77%2.75B | -166.27%-1.4B | -1.77B | -2.49B | -619.63M |
Earning after tax | -42.40%2.33B | -84.29%432.12M | 521.50%5.89B | 395.02%5.22B | 262.93%4.05B | 543.77%2.75B | -166.27%-1.4B | -1.77B | -2.49B | -619.63M |
Minority profit | 237.39%8.69M | -88.01%348K | 156.91%6.38M | 197.27%5.92M | -764.50%-6.33M | 275.35%2.9M | -1,659.81%-11.21M | ---6.09M | --952K | ---1.66M |
Profit attributable to shareholders | -42.70%2.32B | -84.28%431.77M | 524.45%5.88B | 395.71%5.21B | 263.12%4.06B | 544.49%2.75B | -164.45%-1.39B | -1.76B | -2.49B | -617.98M |
Basic earnings per share | -40.35%0.68 | -83.12%0.13 | 528.21%1.67 | 402.04%1.48 | 262.86%1.14 | 552.94%0.77 | -160.00%-0.39 | -0.49 | -0.7 | -0.17 |
Diluted earnings per share | -40.54%0.66 | -84.00%0.12 | 517.95%1.63 | 393.88%1.44 | 258.57%1.11 | 541.18%0.75 | -160.00%-0.39 | -0.49 | -0.7 | -0.17 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data